Cited by 174Acute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentHematopoietic Stem Cell Transplantation

Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes

Champion, Kim M., Gilbert, James G. R., Asimakopoulos, Fotios A., Hinshelwood, Stephen, Green, Anthony R.·1997·British Journal of Haematology

Abstract

Studies of X chromosome inactivation patterns are central to many aspects of our understanding of the pathogenesis of haematological malignancies. In patients with myeloproliferative disorders and myelodysplastic syndromes the demonstration of skewed X inactivation patterns in multiple haemopoietic lineages has been taken to indicate a stem cell origin for these groups of diseases. However, stem cell depletion or selection pressures can also produce skewed X inactivation patterns and might increase with age. We have therefore used the HUMARA assay to study X inactivation patterns of elderly patients with myeloproliferative disorders together with an age-matched control group of normal elderly women. A clonal pattern (clonal granulocytes and polyclonal T cells) was observed in 23.1% of normal women and 63.4% of patients with myeloproliferative disorders. This is the first report of X inactivation patterns in purified subpopulations of blood cells in normal elderly women. These results have three significant implications. Firstly, the finding of clonal granulocytes and polyclonal T cells in normal elderly women is likely to reflect age-related stem cell depletion or selection pressures. Secondly, the demonstration of clonal granulocytes and polyclonal T cells is not a useful diagnostic marker for myeloproliferative disorders or myelodysplastic syndromes in elderly women. Thirdly, our data raise the possibility that clonal blood cell patterns may precede rather than follow mutations which subsequently give rise to myelodysplastic or myeloproliferative phenotypes.

Integrity signals

Registry

Crossref · 10.1046/j.1365-2141.1997.1933010.x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • With aging, blood cells come from fewer and fewer stem cells.

    “during aging, blood cells are derived from fewer and fewer stem cells.”

    From Aging of hematopoietic stem cells (2018) · cites this paper as [80]

  • As these HSCs clonally expand, they can account for a substantial fraction of steady state hematopoiesis, termed clonal hematopoiesis of indeterminate potential (CHIP).

    “As these HSCs clonally expand, they can account for a substantial fraction of steady state hematopoiesis, termed clonal hematopoiesis of indeterminate potential (CHIP) (Busque et al., 1996; Champion et al., 1997; Vas et al., 2012).”

    From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Champion et al., 1997

  • In some elderly individuals, HSCs acquire oncogenic mutations that allow them to outcompete their neighbors and clonally expand.

    “However, in some elderly individuals, HSCs acquire oncogenic mutations that allow them to outcompete their neighbors and clonally expand.”

    From Unraveling Hematopoiesis through the Lens of Genomics (2020) · cites this paper as Champion et al., 1997

  • Non-random X-chromosome inactivation in blood cells increases in frequency with age.

    “Importantly, non-random XCI in blood cells was observed to increase in frequency with age, although the underlying mechanism was unclear 19.”

    From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [19]

Cited by

Sorted by citations

Authors
Champion, K. M., Gilbert, J. G. R., Asimakopoulos, F. A., Hinshelwood, S., & Green, A. R.
Affiliations
University of Cambridge (GB)
Venue
British Journal of Haematology
Publisher
Wiley
Published
1997-06
Volume
97
Issue
4
Pages
920-926
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W2028835250
Cited by
171
References
0
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 9 · 2021: 10 · 2020: 5 · 2019: 7 · 2018: 3 · 2017: 9 · 2016: 4 · 2015: 1 · 2014: 5 · 2013: 2 · 2012: 1
FWCI
5.00
Type
journal article
Language
en
Open access
closed
Locations
  • British Journal of Haematology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Wellcome Trust
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Genetics › Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
X chromosome inactivation, myeloproliferative neoplasms, myelodysplastic syndrome, older women, polyclonal T cells, HUMARA assay, stem cell depletion
MeSH terms
Aged, Aged, 80 and over, Clone Cells, Female, Granulocytes, Hematopoiesis, Humans, Middle Aged, Myelodysplastic Syndromes, Myeloproliferative Disorders, T-Lymphocytes, X Chromosome, Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review